Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Confido Medical Centre | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Research has demonstrated that psychedelic compounds possess significant therapeutic potential for a variety of disorders, including depression. Despite these findings, the underlying mechanisms driving the therapeutic efficacy of psychedelics remain elusive. Furthermore, there exists a debate over the contribution of the subjective psychedelic experience to their therapeutic benefits. In this study, virtual reality (VR) is utilized as a tool to replicate the subjective experiences induced by psychedelics, aiming to explore their impact on depressive symptoms within a clinical sample.
The primary objective of this research is to examine the influence of psychedelic-like phenomenology, as simulated through VR, on depressive symptoms. The study is structured into two distinct arms: the experimental condition features 'Psyrreal,' a VR experience designed to emulate psychedelic effects and the control condition which includes 'Routine Realms,' an analogous VR experience devoid of psychedelic elements. A third waiting list condition may be included, dependent on the availability of sufficient participants and resources. Additionally, the study seeks to identify and analyze various potential mediators that might underpin the therapeutic outcomes observed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Psyrreal | Experimental | Psychedelic virtual reality experience. |
|
| Routine Realms | Sham Comparator | A non-psychedelic virtual reality experience that is largely analogous to Psyrreal. |
|
| No intervention | No Intervention | A conditional waiting list condition. This condition may be included, dependent on the availability of sufficient participants and resources. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapeutic Intervention with Psychedelic Virtual Reality | Other | A 55-minute immersive psychedelic virtual reality experience is incorporated into a therapeutic intervention, comprising a preparatory phase and a subsequent integration session based on the individual's experience. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Emotional State Questionnaire 2 depression subscale score from baseline to follow-up | Measurement of the intensity of depressive symptoms during a specified period (suitable for periods longer than a week). | Measured at 3 time-points - on the day 1 of intervention, and two weeks and two months after intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Short mood questionnaire | A short questionnaire based on the Emotional State Questionnaire 2 to evaluate changes in mood on a short time-scale. | Measured at two time-points - baseline and on the day 1 of the intervention.. |
| Emotional State Questionnaire 2 other subscales |
| Measure | Description | Time Frame |
|---|---|---|
| Custom background questionnaire part I | Contains items regarding demographic information and prior experiences with virtual reality. | Measured at one time-point - before the virtual reality experience on the day 1 of the intervention. |
| Custom background questionnaire part II |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Karl Kristjan Kaup, MSc | Contact | +372 5342 8489 | kaup.kristjan@gmail.com | |
| Kadi Tulver, PhD | Contact | +372 522 9245 | kadi.tulver@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Jaan Aru, PhD | University of Tartu | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Confido Medical Centre | Recruiting | Tallinn | Harju | 10138 | Estonia |
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Therapeutic Intervention with Non-Psychedelic Virtual Reality | Other | A 55-minute immersive virtual reality experience is incorporated into a therapeutic intervention, comprising a preparatory phase and a subsequent integration session based on the individual's experience. |
|
These subscales measure symptoms of panic disorder, agoraphobia, generalized anxiety disorder, asthenia and sleeping disorder. |
| Measured at 3 time-points - on the day 1 of intervention and two weeks and two months after intervention. |
| State Mindfulness Scale | Questionnaire for evaluating change in state mindfulness due to virtual reality experience. | Measured at two time-points -baseline and on the day 1 of the intervention |
| Adapted short version of the questionnaire for the assessment of altered states of consciousness (11D-ASC) | Questionnaire to evaluate alterations in consciousness during the virtual reality experience. Some items are adapted for implementation in virtual reality and a subset of questions are omitted from the original 11D-ASC questionnaire. | Measured at one time-point - after the virtual reality experience on the day 1 of the intervention. |
| Psychological Insight Questionnaire | Questionnaire for measuring psychological insight during acute (psychedelic) experiences. | Measured at one time-point - after the virtual reality experience on the day 1 of the intervention. |
| Ego-Dissolution Inventory | Questionnaire for measuring the experience of ego-dissolution during the virtual reality experience. | Measured at one time-point - after the virtual reality experience on the day 1 of the intervention. |
| Avoidance/Acceptance-Promoting Experience Questionnaire | Questionnaire for measuring changes in acceptance- and avoidance-related beliefs due to virtual reality experiences. | Measured at one time-point - after the virtual reality experience on the day 1 of the intervention. |
| Awe Experience Scale | Questionnaire for measuring the experience of awe during the virtual reality experience. | Measured at one time-point - after the virtual reality experience on the day 1 of the intervention. |
Contains items on prior experiences with psychedelics and spiritual practices, and the subjective impression of the intervention. |
| Measured at one time-point - at the two month follow-up. |
| Semi-structured interview transcriptions | If the participant agrees, the post-experience integration session will be recorded and transcribed. | Measured at one time-point - immediately after the virtual reality experience on the day 1 of the intervention. |